TENAX THERAPEUTICS, INC. 4
4 · TENAX THERAPEUTICS, INC. · Filed Dec 20, 2016
Insider Transaction Report
Form 4
Jebsen Michael B
Chief Financial Officer
Transactions
- Disposition to Issuer
common stock
2016-12-19$2.07/sh+49$101→ 68,256 total
4 · TENAX THERAPEUTICS, INC. · Filed Dec 20, 2016
common stock